Huntington disease

Last updated: May 20, 2023

Huntington disease

Watch later

Watch later

Hypokalemia: Clinical
Movement of water between body compartments
The role of the kidney in acid-base balance
Blood histology
Blood components
Respiratory acidosis
Metabolic acidosis
Respiratory alkalosis
Metabolic alkalosis
Metabolic and respiratory alkalosis: Clinical
Metabolic and respiratory acidosis: Clinical
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Chronic obstructive pulmonary disease (COPD): Clinical
Chronic obstructive pulmonary disease (COPD): Nursing process (ADPIE)
Adrenergic antagonists: Alpha blockers
Sympatholytics: Alpha-2 agonists
Alpha-2 adrenergic agonists: Nursing pharmacology
Adrenergic receptors
Adrenergic antagonists: Beta blockers
Diabetes mellitus: Clinical
Diabetes mellitus (DM): Nursing process (ADPIE)
Diabetes mellitus
Diabetes mellitus: Pathology review
Stroke: Nursing process (ADPIE)
Stroke: Clinical
Ischemic stroke
Intracerebral hemorrhage
Peptic ulcers and stomach cancer: Clinical
GERD, peptic ulcers, gastritis, and stomach cancer: Pathology review
Sickle cell disease (NORD)
Sickle cell disease: Nursing process (ADPIE)
Sickle cell disease: Clinical
Blood groups and transfusions
Erythropoietin
Blood products: Nursing pharmacology
Oxygen binding capacity and oxygen content
Blood products and transfusion: Clinical
Hemophilia
Hemophilia: Nursing process (ADPIE)
Leukemia: Nursing process (ADPIE)
Chronic leukemia
Leukemias: Pathology review
Acute leukemia
Leukemia: Clinical
Lymphomas: Pathology review
Lymphoma: Clinical
Non-Hodgkin lymphoma
Hodgkin lymphoma
Lymphatic system anatomy and physiology
Anatomy of the abdominal viscera: Liver, biliary ducts and gallbladder
Liver anatomy and physiology
Cirrhosis
Cirrhosis: Pathology review
Cirrhosis: Clinical
Cirrhosis: Nursing process (ADPIE)
Hepatitis C virus
Hepatitis A and Hepatitis E virus
Liver cancer: Nursing
Cholestatic liver disease
Non-alcoholic fatty liver disease
HIV (AIDS)
HIV and AIDS: Pathology review
Antiretrovirals for HIV/AIDS - Protease inhibitors: Nursing pharmacology
Antiretrovirals for HIV/AIDS - NRTIs and NNRTIs: Nursing pharmacology
Antiretrovirals for HIV/AIDS - Integrase strand transfer inhibitors: Nursing pharmacology
Anatomy of the abdominal viscera: Pancreas and spleen
Pancreatitis: Nursing process (ADPIE)
Glaucoma: Nursing process (ADPIE)
Glaucoma
Eye conditions: Refractive errors, lens disorders and glaucoma: Pathology review
Acute respiratory distress syndrome (ARDS): Nursing
Anatomy of the coronary circulation
Coronary artery disease: Pathology review
Coronary artery disease: Clinical
ECG basics
ECG normal sinus rhythm
ECG rate and rhythm
ECG axis
ECG intervals
ECG QRS transition
ECG cardiac infarction and ischemia
Cardiac cycle
Arterial disease
Delirium
Dementia and delirium: Clinical
Vascular dementia
Frontotemporal dementia
Dementia with Lewy bodies
Dementia: Pathology review
Tumor lysis syndrome (TLS): Nursing Process (ADPIE)
Cholelithiasis: Nursing
Coronary artery disease (CAD) and angina pectoris: Nursing process (ADPIE)
Breast cancer: Nursing process (ADPIE)
Ovarian cancer: Nursing
Cervical cancer: Nursing
Hormones and hormone modulators for cancer: Nursing pharmacology
Endometriosis: Nursing
Heart failure
Left-sided heart failure: Nursing process (ADPIE)
Heart failure: Pathology review
Pneumonia: Pathology review
Pneumonia
Bacterial pneumonia: Nursing process (ADPIE)
Respiratory stimulants: Nursing pharmacology
Corticosteroids - Inhaled: Nursing pharmacology
Pneumothorax and hemothorax: Nursing
Chest trauma: Clinical
Pleural effusion: Nursing
Tuberculosis (TB): Nursing
Parkinson disease: Nursing process (ADPIE)
Huntington disease
Multiple sclerosis (MS): Nursing
Multiple sclerosis
Guillain-Barré syndrome: Nursing
Guillain-Barre syndrome
Myasthenia gravis: Nursing
Acute kidney injury (AKI): Nursing process (ADPIE)
Acute kidney injury: Clinical
Chronic kidney disease (CKD): Nursing
Chronic kidney disease
Chronic kidney disease: Clinical
Polycystic kidney disease (PKD): Nursing
Renin-angiotensin-aldosterone system
Osteoarthritis: Nursing
Osteoarthritis
Rheumatoid arthritis (RA): Nursing process (ADPIE)
Rheumatoid arthritis: Clinical
Rheumatoid arthritis
Rheumatoid arthritis and osteoarthritis: Pathology review
Systemic lupus erythematosus
Systemic lupus erythematosus (SLE): Pathology review
Systemic lupus erythematosus (SLE): Clinical
Systemic lupus erythematosus (SLE): Nursing
Mycobacterium tuberculosis (Tuberculosis)
Peripheral venous disease (PVD): Nursing process (ADPIE)
Peripheral arterial disease (PAD): Nursing process (ADPIE)
Buerger disease: Nursing
Raynaud phenomenon: Nursing
Aortic dissections and aneurysms: Pathology review
Aortic aneurysms and dissections: Clinical
Aortic dissection
Aortic aneurysm: Nursing process (ADPIE)
Venous thromboembolism (VTE): Nursing process (ADPIE)
Benign prostatic hyperplasia (BPH): Nursing process (ADPIE)
Benign prostatic hyperplasia
Prostate cancer: Nursing
Prostate cancer
Testicular cancer: Nursing
Testicular cancer
Diabetic ketoacidosis (DKA): Nursing process (ADPIE)
Endocrine system anatomy and physiology
Vitamin B12 deficiency
Thalassemia: Nursing
Anemia - Iron-deficiency: Nursing
Anemia - Macrocytic: Nursing
Anemia - Aplastic: Nursing
Thyroid hormones
Medications for thyroid disorders: Nursing pharmacology
Hyperthyroidism: Nursing process (ADPIE)
Hypothyroidism: Nursing process (ADPIE)
Hypoparathyroidism: Nursing
Hyperparathyroidism: Nursing
Anxiety disorders: Nursing process (ADPIE)
Spinal cord injury (SCI): Nursing
Cluster A personality disorders
Smoke inhalation injury: Nursing process (ADPIE)
Shock - Anaphylactic: Nursing
Shock - Obstructive: Nursing
Shock - Neurogenic: Nursing
Shock - Hypovolemic: Nursing
Shock - Cardiogenic: Nursing
Shock - Septic: Nursing
Pulmonary edema: Nursing
Burn injury: Nursing

Transcript

Watch video only

Huntington disease, or HD, is a rare neurodegenerative disease that involves a repeated sequence of DNA that causes an abnormal protein to form, leading to abnormal movements and cognitive problems.

Huntington disease is an autosomal dominant genetic disorder, which means that one affected copy of a gene is enough to cause disease. Affected people are typically present in each generation, because an affected person (male or female) has a 50% chance of passing on the affected gene to a child, which causes that child to have the disease.

In most people, a gene called huntingtin or HTT on chromosome 4, contains a triplet repeat, where the nucleotides C, A, and G are repeated 10-35 times in a row. In people with Huntington disease, this repeat goes on for 36 or more times in a row. CAG codes for the amino acid glutamine, so people with Huntington disease patients will have 36 or more glutamines in a row in the huntingtin protein. So, in addition to being a triplet repeat disorder, HD is, more specifically, a “polyglutamine” disease.

The specific way in which extra glutamines cause HD symptoms isn’t fully worked out, but some clues are that the mutated protein aggregates within the neuronal cells of the caudate and putamen of the basal ganglia causing neuronal cell death. Cell death might be related to excitotoxicity – which is excessive signaling of these neurons, which leads to high intracellular calcium.

The expanded CAG repeats not only affect the huntingtin protein – they affect DNA replication itself. When copying the HTT gene, DNA polymerase can basically lose track of which CAG it’s on and accidently add extra CAGs. Since as a zygote develops into a fetus and eventually into a full adult, by the time sperm and eggs are created, several dozen cell divisions, each with a round of DNA replication have taken place, and so there have already been ample opportunities for repeat expansion, and the more repeats that’re added, the more unstable it gets.

This expansion of the originally inherited gene means a child of a parent with HD can inherit even more CAG repeats than the parent did. The higher the number of repeats in the protein, the earlier the age when a person starts having symptoms. This phenomenon is called anticipation, which means that Huntington disease families often show earlier symptom onset with each generation. Even repeats of 27-35 CAGs can expand occasionally; these are called “pre-mutation” alleles, since they don’t cause the disease, but they’re set-up for developing a mutation of 36 or more CAGs.

This process of adding more repeats is called repeat expansion and it happens way more in the production of sperm than of eggs, so both anticipation and new disease alleles generally happens when the father is the affected parent. When a person has 40+ repeats, they show 100% penetrance and they will have the disease. For reasons that remain unknown, people with 36-39 repeats can show reduced penetrance; some may have symptoms while others may not. Because of this penetrance, the test for HD, which counts the number of CAG repeats, is really good at determining whether HD will develop in an at-risk individual.